Literature DB >> 15588224

Interleukin 21: a key player in lymphocyte maturation.

Stephen L Nutt1, Jason Brady, Yoshihiro Hayakawa, Mark J Smyth.   

Abstract

The common gamma chain family of cytokine receptors plays a plethora of roles during the early development, activation, and terminal differentiation of the lymphocyte lineages. The most recently identified member of this family, the IL-21R, is expressed to varying degrees on B, T lymphocytes, and natural killer (NK) cells, whereas IL-21, is reportedly only produced by activated CD4+ T cells. In keeping with this expression pattern the IL-21:IL-21R interaction is important for the latter stages and function of all three lymphoid lineages. IL-21 is a regulator of A-cell differentiation to plasma cells as well as immunoglobulin class switching. In contrast, within the T-cell lineage, IL-21 acts as a co-stimulator of proliferation, enhances memory response, and modulates homeostasis. Within the innate immune system IL-21 has a role in the terminal differentiation of NK cells, enhancing cytotoxic function while also decreasing cellular viability. These immune maturation and stimulating functions have resulted in IL-21 being tested in a variety of models of immunity. In these contexts, IL-21 has shown very promising efficacy in a number of antitumor immune responses mediated by NK and or T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588224     DOI: 10.1615/critrevimmunol.v24.i4.20

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  6 in total

1.  Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.

Authors:  Costin Tomescu; Domenico Mavilio; Luis J Montaner
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

2.  Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1.

Authors:  Consuelo Ortega; Orlando A Estévez; Silvia Fernández; Rocío Aguado; José M Rumbao; Teresa Gonzalez; Juan L Pérez-Navero; Manuel Santamaría
Journal:  Clin Vaccine Immunol       Date:  2013-03-06

Review 3.  Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity.

Authors:  Theodore F Logan; Michael J Robertson
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.945

4.  KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.

Authors:  Cristina Morales-Estevez; Juan De la Haba-Rodriguez; Barbara Manzanares-Martin; Ignacio Porras-Quintela; Antonio Rodriguez-Ariza; Alberto Moreno-Vega; Maria J Ortiz-Morales; Maria A Gomez-España; Maria T Cano-Osuna; Javier Lopez-Gonzalez; Beatriz Chia-Delgado; Rafael Gonzalez-Fernandez; Enrique Aranda-Aguilar
Journal:  Front Immunol       Date:  2016-12-05       Impact factor: 7.561

5.  Alteration of Multiple Leukocyte Gene Expression Networks is Linked with Magnetic Resonance Markers of Prognosis After Acute ST-Elevation Myocardial Infarction.

Authors:  A Teren; H Kirsten; F Beutner; M Scholz; L M Holdt; D Teupser; M Gutberlet; J Thiery; G Schuler; I Eitel
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

6.  Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer.

Authors:  Alica Linnebacher; Philipp Mayer; Nicole Marnet; Frank Bergmann; Esther Herpel; Steffie Revia; Libo Yin; Li Liu; Thilo Hackert; Thomas Giese; Ingrid Herr; Matthias M Gaida
Journal:  Cells       Date:  2019-09-18       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.